Position in RARE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$31,436,058
-$10,568,727 QoQ
Shares Held
1,500,528
-17.8% QoQ
Ownership
1.52%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 89.24232003668043.ToString("F0")%
Shared 0.ToString("F0")%
None 10.757679963319578.ToString("F0")%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. RARE ranks #73 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in RARE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,436,058 | 1,500,528 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $42,004,785 | 1,826,295 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $27,378,299 | 910,183 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $23,229,636 | 638,879 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $22,681,939 | 626,400 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $25,165,807 | 598,189 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $25,988,284 | 467,836 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $20,466,521 | 497,969 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $23,549,593 | 504,382 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $28,574,788 | 597,549 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $17,664,180 | 495,489 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $23,857,280 | 517,175 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,372,236 | 358,410 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,285,712 | 308,347 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $16,568,674 | 400,113 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $19,666,855 | 329,649 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $17,772,944 | 244,739 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $16,145,613 | 192,004 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $20,659,730 | 229,069 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $37,195,840 | 390,098 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $27,005,541 | 237,182 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $34,791,333 | 251,328 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $9,983,864 | 121,473 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,376,379 | 94,303 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,581,723 | 80,615 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||